Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology innovation, today announced data from an investigator-initiated Phase II trial at Memorial Sloan Kettering Cancer Center, investigating ...

First study of agenT-797, botensilimab (BOT) and balstilimab (BAL) in gastroesophageal cancer shows disease control rate (DCR) in 77% of patients ...

Asgard’s immunotherapy, AT-108, induces systemic, dose-dependent efficacy with broad tumor activity in preclinical studies ...

The immune cells are a key part of the body that keep humans healthy. But that also means when the cells age, the body grows ...

Asgard’s immunotherapy, AT-108, induces systemic, dose-dependent efficacy with broad tumor activity in preclinical studies and key biomarkers identifiedAT-108 combines the advantages of an off-the-she ...

If you’re confused about the growing landscape of weight loss drugs, here is a concise breakdown of their mechanisms, ...

The Hawaiʻi Department of Transportation notifies highway users that the traffic signal at Kamehameha Avenue and Puʻunēnē ...

Rocket Doctor AI Inc. ("Rocket Doctor AI") announces that, subject to regulatory approval, it has entered into an addendum to the agreement originally entered into on July 18, 2025, to further engage ...

Scholar Rock today announced that the company granted inducement equity awards covering an aggregate of 89,304 shares of its common stock to nine newly hired employees, consisting of inducement stock ...

The unlikely star of a recent marathon livestream was a robot on a factory assembly line -- and it kept viewers glued for eight straight hours. On Tuesday, AgiBot, a Shanghai-based embodied AI company ...

Board of Alders New Haven Notice] The Joint Community Development/Health & Human Services Committee will meet in person on Thursday, May 28, 2026, at 6:00 P.M, in the Board of Alders Chamber, 165 ...

Think only Japanese engines are reliable? These 10 powerplants from BMW, GM, Ford and others prove there are excellent ...